Rapamycin inhibits the PI3K/Akt/mTOR pathway, thereby inhibiting the differentiation of fibroblasts in nasal polyps and the production of collagen and extracellular matrix, and attenuating the occurrence of tissue remodeling.19 The gene discussed is AKT1; the disease is nasal cavity polyp.